These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9374327)

  • 21. Radiopharmaceuticals in clinical trials.
    Holmes RA
    Semin Oncol; 1993 Jun; 20(3 Suppl 2):22-6. PubMed ID: 7684861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cancer therapy using bone-seeking isotopes.
    Lewington VJ
    Phys Med Biol; 1996 Oct; 41(10):2027-42. PubMed ID: 8912378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Samarium-153-EDTMP biodistribution and dosimetry estimation.
    Eary JF; Collins C; Stabin M; Vernon C; Petersdorf S; Baker M; Hartnett S; Ferency S; Addison SJ; Appelbaum F
    J Nucl Med; 1993 Jul; 34(7):1031-6. PubMed ID: 7686217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone refractory prostatic cancer: the role of radiolabelled diphosphonates and growth factor inhibitors.
    Scher HI; Curley T; Yeh S; Tong W; O'Moore PV; Larson S
    Adv Exp Med Biol; 1992; 324():115-29. PubMed ID: 1283494
    [No Abstract]   [Full Text] [Related]  

  • 25. Samarium-153-EDTMP in bone metastases.
    Ahonen A; Joensuu H; Hiltunen J; Hannelin M; Heikkilä J; Jakobsson M; Jurvelin J; Kairemo K; Kumpulainen E; Kulmala J
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):123-7. PubMed ID: 7543288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Palliative treatment of metastasic bone pain].
    Pons F; Fuster D; Vidal-Sicart S
    Rev Esp Med Nucl; 2003 Nov; 22(6):429-38. PubMed ID: 14588238
    [No Abstract]   [Full Text] [Related]  

  • 27. [Bone metastases treated with radiopharmaceuticals].
    Giammarile F
    Bull Cancer; 2013 Nov; 100(11):1223-7. PubMed ID: 24409472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of samarium-153-ethylenediaminetetramethylene phosphonic acid with pamidronate disodium in the treatment of patients with painful metastatic bone cancer.
    Wang RF; Zhang CL; Zhu SL; Zhu M
    Med Princ Pract; 2003; 12(2):97-101. PubMed ID: 12634464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Samarium-153 ethylenediamine tetramethylene phosphonate therapy for bone pain palliation in skeletal metastases.
    Tripathi M; Singhal T; Chandrasekhar N; Kumar P; Bal C; Jhulka PK; Bandopadhyaya G; Malhotra A
    Indian J Cancer; 2006; 43(2):86-92. PubMed ID: 16790946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bony metastases seen on scintigraphy with samarium-153.
    Verma N; Singh-Wadhwa S; Chan WL
    Clin Nucl Med; 2002 Mar; 27(3):207. PubMed ID: 11852311
    [No Abstract]   [Full Text] [Related]  

  • 31. Internally administered isotopes in the treatment of solid malignancy.
    Willett CG
    J Nucl Med; 1990 May; 31(5):601-2. PubMed ID: 2341895
    [No Abstract]   [Full Text] [Related]  

  • 32. Pronounced therapeutic effect of samarium 153-ethylenediaminetetramethylene phosphonate in an orthotopic human osteosarcoma tibial tumor model.
    Winderen M; Kjønniksen I; Fodstad O
    J Natl Cancer Inst; 1995 Feb; 87(3):221-2. PubMed ID: 7707409
    [No Abstract]   [Full Text] [Related]  

  • 33. [Analgesic response and secondary effects in patients with osteoblastic metastasis, treated with Samarium 153 ethylenediaminotetramethylenephosphate].
    Lovera C; Massardo T; Galleguillos MC; González P; Comparini B; Yáñez M; Fodor M; Gil MC; Araya G; Tomicic M
    Rev Med Chil; 1998 Aug; 126(8):963-71. PubMed ID: 9830748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial.
    Collins C; Eary JF; Donaldson G; Vernon C; Bush NE; Petersdorf S; Livingston RB; Gordon EE; Chapman CR; Appelbaum FR
    J Nucl Med; 1993 Nov; 34(11):1839-44. PubMed ID: 8229221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palliation of bone pain in patients with metastatic cancer using strontium-89 (Metastron).
    Kan MK
    Cancer Nurs; 1995 Aug; 18(4):286-91. PubMed ID: 7545083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pain palliative therapy in women with breast cancer osseous metastatic disease and the role of specific serum cytokines as prognostic factors.
    Iakovou I; Doumas A; Badiavas K; Mpalaris V; Frangos S; Farmakis G
    Cancer Biother Radiopharm; 2014 Apr; 29(3):116-23. PubMed ID: 24392878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complete scintigraphic lesion regression after single 153Sm-EDTMP therapy in prostate cancer.
    Weiss K; Köck HH; Atefie K; Sinzinger H
    Rev Esp Med Nucl; 2001 Jun; 20(4):311-2. PubMed ID: 11940421
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapy of metastatic bone pain.
    Serafini AN
    J Nucl Med; 2001 Jun; 42(6):895-906. PubMed ID: 11390554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone.
    Rudavsky AZ; Freeman LM
    J Clin Endocrinol Metab; 1997 Jan; 82(1):11-4. PubMed ID: 8989223
    [No Abstract]   [Full Text] [Related]  

  • 40. [The value of Sm-153-EDTMP for treatment of metastatic bone pain and improving quality of life].
    Jiang CY; Zhu BL; Zhang YJ
    Zhonghua Zhong Liu Za Zhi; 1994 Mar; 16(2):118-21. PubMed ID: 7523052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.